Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

FDA May Cut Its Losses In Off-Label Promotion Case

This article was originally published in The Pink Sheet Daily

Executive Summary

Amarin, FDA exploring settlement of Vascepa suit; agency could allow Amarin to proceed with its statements and disclosures rather than risk a difficult appeal to Second Circuit, the same court that handed FDA a loss in Caronia three years ago.


Related Content

Off-Label Enforcement, Not Promotion, May See First Changes After Free Speech Ruling


Related Companies